Skip to main content
Figure 5 | BMC Veterinary Research

Figure 5

From: CTLA4 overexpressing adipose tissue-derived mesenchymal stem cell therapy in a dog with steroid-refractory pemphigus foliaceus

Figure 5

Changes in body weight and blood profile after CTLA4 overexpressing ATMSCs (CTLA4-ATMSCs) and/or ATMSCs treatment. An increase in body weight (A) a reduction in number of leukocytes (B), an increase in the RBC count (C) and packed cell volume (PCV) (D) and a decrease in the liver enzyme concentration (E) are shown. Arrow heads indicate the time of CTLA4-ATMSCs administration and arrows indicate the time of naive ATMSCs administration.

Back to article page